Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma.

Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma.

While tumor resection and liver transplantation (LT) represent potentially curative therapeutic options for patients with early-stage hepatocellular carcinoma (HCC), the identification of the ideal surgical candidates has remained challenging. Just recently, miRNA-193a-5p was described as a tumor su...

Full description

Bibliographic Details
Main Authors: Sven H Loosen, Theresa H Wirtz, Sanchari Roy, Mihael Vucur, Mirco Castoldi, Anne T Schneider, Christiane Koppe, Tom F Ulmer, Anjali A Roeth, Jan Bednarsch, Patrick H Alizai, Pia Paffenholz, Münevver Demir, Christian Trautwein, Frank Tacke, Ulf P Neumann, Christoph Roderburg, Tom Luedde
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0239386

Internet

https://doi.org/10.1371/journal.pone.0239386

Similar Items